Novo Nordisk launches new 100% renewable power target for suppliers
21 September - Novo Nordisk today announced an ambitious target to ensure all its direct suppliers supply the company based on 100% renewable power by 2030. Novo Nordisk will work with all existing and new suppliers to meet the target. The plan will be presented in connection with Climate Week NYC hosted this week in association with the United Nations and the City of New York. This commitment is the next step in Novo Nordisk’s ‘Circular for Zero’ environmental strategy, which launched in April 2019 and set an ultimate ambition for the company to have zero environmental impact.
24 September - In connection with the 56th European Association for the Study of Diabetes (EASD) Annual Meeting 2020, Novo Nordisk today announced the results of the CAPTURE study, a global non-interventional study to uncover the prevalence of cardiovascular disease and risk and its management in people living with type 2 diabetes.
Novo Nordisk launches new social responsibility strategy to defeat diabetes
27 May - At a time of acute global health need, Novo Nordisk today announced the launch of a new social responsibility strategy: ‘Defeat Diabetes’. The strategy strengthens Novo Nordisk’s commitment and introduces new long-term ambitions to provide access to affordable diabetes care to vulnerable patients in every country and to ensure that no child should die from type 1 diabetes.
Recycling an insulin pen is a lot harder than it sounds. But might there come a day when all insulin pens can be re-purposed after use? And what more can we do to help solve the world’s growing plastic challenge?